PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+25.21%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$13.9M
AUM Growth
+$13.9M
(-75%)
Cap. Flow
-$45.4M
Cap. Flow
% of AUM
-326.16%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
83
New
14
Increased
3
Reduced
23
Closed
37
Top Buys
| 1 |
Biogen
BIIB
|
$546K |
| 2 |
Elevance Health
ELV
|
$504K |
| 3 |
Humana
HUM
|
$494K |
| 4 |
Centene
CNC
|
$430K |
| 5 |
Pfizer
PFE
|
$294K |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
$2.23M |
| 2 |
Microchip Technology
MCHP
|
$2.23M |
| 3 |
Zimmer Biomet
ZBH
|
$2.09M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$2.03M |
| 5 |
Twilio
TWLO
|
$1.74M |
Sector Composition
| 1 | Healthcare | 91.76% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
| $1.07M | 7.65% | 17,795 -7,575 | -30% | -$453K |
|
|
ALXN
2
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $911K | 6.54% | 8,421 -13,715 | -62% | -$1.48M |
|
|
ALNA
3
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $776K | 5.57% | 284,285 | – | – |
|
4
Gilead Sciences
GILD
$140B
| $708K | 5.08% | 10,898 -17,604 | -62% | -$1.14M |
|
5
Penumbra
PEN
$10.6B
| $608K | 4.37% | 3,699 -8,859 | -71% | -$1.46M |
|
|
6
Zimmer Biomet
ZBH
$21B
| $552K | 3.96% | 3,689 -13,999 | -79% | -$2.09M |
|
|
7
Biogen
BIIB
$19.4B
| $546K | 3.92% | +1,839 | New | +$546K |
|
|
NVRO
8
DELISTED
NEVRO CORP.
NVRO
| $531K | 3.81% | 4,515 -1,252 | -22% | -$147K |
|
|
9
Elevance Health
ELV
$71.8B
| $504K | 3.62% | +1,669 | New | +$504K |
|
|
10
Humana
HUM
$36.5B
| $494K | 3.55% | +1,347 | New | +$494K |
|
11
Cigna
CI
$80.3B
| $453K | 3.25% | 2,216 -4,916 | -69% | -$1M |
|
12
IQVIA
IQV
$32.4B
| $452K | 3.25% | 2,926 -5,641 | -66% | -$871K |
|
|
13
BioMarin Pharmaceuticals
BMRN
$11.2B
| $451K | 3.24% | 5,329 -24,012 | -82% | -$2.03M |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $436K | 3.13% | 18,035 +1,304 | +8% | +$31.5K |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $436K | 3.13% | 2,282 -5,092 | -69% | -$973K |
|
|
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $431K | 3.09% | 9,484 -19,393 | -67% | -$881K |
|
|
17
Centene
CNC
$14.3B
| $430K | 3.09% | +6,838 | New | +$430K |
|
18
Novartis
NVS
$245B
| $392K | 2.81% | 4,270 -6,441 | -60% | -$591K |
|
19
HCA Healthcare
HCA
$94.5B
| $345K | 2.48% | 2,335 -5,165 | -69% | -$763K |
|
|
20
Pfizer
PFE
$141B
| $294K | 2.11% | +7,492 | New | +$294K |
|
21
ICU Medical
ICUI
$3.15B
| $258K | 1.85% | +1,381 | New | +$258K |
|
|
DERM
22
DELISTED
Dermira, Inc.
DERM
| $256K | 1.84% | 16,892 -13,106 | -44% | -$199K |
|
23
Icon
ICLR
$13.8B
| $241K | 1.73% | 1,402 -1,810 | -56% | -$311K |
|
24
UnitedHealth
UNH
$281B
| $233K | 1.67% | +791 | New | +$233K |
|
25
iRhythm Technologies
IRTC
$5.46B
| $231K | 1.66% | 3,389 -9,372 | -73% | -$639K |
|